Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Scavuzzo MA
Metastatic Castration-Resistant Prostate Cancer: Critical Review of MDV-3100
InChi: InChI=1S/C30H47N5O2/c1-22(2)35-17-12-24(13-18-35)31-30-25-20-27(36-3)28(37-19-9-16-34-14-7-8-15-34)21-26(25)32-29(33-30)23-10-5-4-6-11-23/h20-24H
FOY-251 inhibits the proteolytic activity of prostasin
54(6):352-8
Dapagliflozin chin gallate Scavuzzo MADapagliflozin, also known as BMS 512148, is a drug used to treat type 2 diabetes approved in 2012 by FDA. Dapagliflozin inhibits subtype 2 of the sodium glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter mechanism causes blood glucose to be eliminated through the urine. In clinical trials, dapagliflozin lowered HbA1c by 0. 6 versus placebo percentage points